Clinical-stage biopharma firm Vasomune Therapeutics has dosed the first subjects in a Phase I study of its potential vascular normalisation Covid-19 …, Clinical-stage biopharma firm Vasomune Therapeutics has dosed the first subjects in a Phase I study of its potential vascular normalisation Covid-19 …, Read More